Rheumatology round-up

The presence of anticyclic citrullinated peptide antibodies is not linked with a greater risk of cardiovascular disease in rheumatoid arthritis (RA), according to findings from a Dutch study in The Journal of Rheumatology.

Instead, their follow-up of a cohort of 929 patients with RA over a median 7.5 years found an association between rheumatoid factor and risk of developing CVD.

Methotrexate has been shown in meta-analyses